Pharma

Your Article Summary

See Latest Articles

Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09

Gilead Sciences, Inc. and GlaxoSmithKline (NYSE:GSK) today announced a licensing agreement to commercialize Viread(R) for the treatment of chronic hepatitis B infection in adults in five countries in Asia. The companies' combined commercialization activities will expand access to Viread for the treatment of HBV, once approved, to patients in Asia where the prevalence in most countries is greater than 8 percent.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

US FDA approves new indication for CRESTOR
AstraZeneca, 02/09/10

Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Abbott, 02/09/10

FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
The Oncologist, 02/09/10

 See all of Drug/Product Approvals

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

AstraZeneca and Dako sign agreement to develop companion diagnostics for cancer treatments
AstraZeneca, 02/08/10

GEH and Exelon Sign Deal to Supply Cobalt-60
Imaging Economics, 02/05/10

BioMarin to Acquire LEAD Therapeutics
BioMarin, 02/05/10

 See all of M&A/Partnerships